These publicly reported settlements illustrate the scale of whistleblower-driven recoveries under federal fraud statutes.
One of the largest healthcare fraud settlements in U.S. history, resolving allegations of unlawful promotion of prescription drugs and false claims to government healthcare programs. Whistleblowers played a central role.
A global pharmaceutical manufacturer resolved civil and criminal claims tied to off-label promotion and kickbacks. Relators under the False Claims Act shared a substantial reward.
A major defense contractor resolved allegations of overcharging the U.S. military and failing to comply with pricing-compliance requirements on federal contracts.
A health plan resolved allegations of submitting inaccurate diagnosis data to boost risk-adjusted Medicare payments — a matter originated by a whistleblower insider.
An SEC whistleblower case resolving disclosure and reporting failures. Qualifying relators under the SEC Whistleblower Program may receive 10%–30% of sanctions collected over $1 million.
A medical device manufacturer resolved allegations of improper financial inducements to physicians in violation of the Anti-Kickback Statute and False Claims Act.
A contractor resolved allegations it supplied non-conforming parts to federal agencies and submitted false certifications of compliance.
An importer resolved allegations of misclassifying and undervaluing goods to avoid customs duties — a reverse false-claims matter.
Amounts referenced are publicly reported figures illustrative of whistleblower-driven recoveries. They are not representative of any individual client outcome.
Call today for a free confidential consultation. First-to-file matters.